Results 91 to 100 of about 5,087,038 (341)
Assessment of the Stability of Insurance Companies: The Case of Baltic Non-Life Insurance Market
Economics and Business, 2018 The study gives an overview of the Baltic non-life insurance market. The purpose of the research is to summarise stability statistics on solvency ratios, risk profiles and capital surplus, which was contained in Solvency and Financial Condition reports ...
Zariņa Ilze +2 more
doaj +1 more source
Ryzyko zakładów ubezpieczeń w świetle nowych wymogów kapitałowych Solvency II
Problemy Zarządzania, 2013 The aim of this work is to conduct the key aspects of a heated debate about effects and issues connected with implementing a new solution of risk management in insurance companies included in Solvency II.
Teresa Czerwińska
doaj +1 more source
Szolvenciatőke mint fixpont (Solvency Capital as a Fixpoint) [PDF]
, 2014 A tanulmányban a szerző a fixpont-iteráció témájával foglalkozik egy elméleti modellben, a biztosítók szolvenciatőkéjének számolásával kapcsolatban. A téma aktualitását a biztosítók tőkemegfelelésével összefüggő Szolvencia II.
Szüle, Borbála
core
Bond portfolio management under Solvency II regulation
European Journal of Finance, 2020 We develop a novel approach to the bond portfolio optimization for insurance companies that are subject to the new Solvency II regulation. The regulatory efficient portfolios are determined using the Non-dominated Sorting Genetic Algorithm II (NSGA-II ...
Mikica Drenovak +3 more
semanticscholar +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Molecular Oncology, EarlyView.Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Investment Potential of Insurance Companies: Ukrainian and European Experience [PDF]
Problemi EkonomikiThe article examines the investment potential of insurance companies as a factor in stabilizing the country’s financial system. The main focus is on analyzing the regulatory requirements in the European Union and the possibilities for their ...
Liutyi Ihor O. , Lialkin Oleksandr S.
doaj +1 more source
In this paper we discuss some issues proposed in the Solvency II - QIS3 report. In particular we comment and discuss the \AISAM-ACME study on non-life long tail liabilities; reserve risk and risk margin assessment under Solvency II".
Dhaene, Jan +2 more
core
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
FEBS Open Bio, EarlyView.This research protocol outlines a workflow for nuclear magnetic resonance (NMR)‐based metabolomics in the agri‐food sector. Using two case studies—strawberry leaves (solid matrix) and wine (liquid matrix)—it details the procedures for sample preparation, data acquisition, and processing.
Andrea Fernández‐Veloso +4 more
wiley +1 more source
A correlation sensitivity analysis of non-life underwriting risk in solvency capital requirement estimation [PDF]
This paper analyses the impact of using different correlation assumptions between lines of business when estimating the risk-based capital reserve, the Solvency Capital Requirement (SCR), under Solvency II regulations.
Antoni Ferri +2 more
core +3 more sources